特纳综合征 中国就医指南

Turner syndrome is a chromosomal disorder affecting females, characterized by the complete or partial absence of one X chromosome (karyotype 45,X or variants such as mosaicism 45,X/46,XX, isochromosome Xq, or Xp deletions). It occurs exclusively in individuals with female phenotypic development and results from nondisjunction during parental gametogenesis—most commonly paternal meiotic error. The underlying pathogenesis involves haploinsufficiency of genes on the X chromosome critical for ovarian development, lymphatic formation, cardiovascular morphogenesis, and skeletal growth—including SHOX (short stature homeobox gene), which contributes significantly to short stature and skeletal anomalies. Epidemiologically, Turner syndrome affects approximately 1 in 2,000–2,500 live female births; however, >99% of 45,X conceptions end in spontaneous miscarriage, making it one of the most common chromosomal causes of pregnancy loss. Risk factors are purely genetic and non-modifiable—advanced maternal age slightly increases incidence, but no environmental, lifestyle, or behavioral risk factors have been identified. Clinical manifestations are highly variable but commonly include short stature (mean adult height ~143 cm without intervention), gonadal dysgenesis leading to primary amenorrhea and infertility, congenital heart defects (e.g., bicuspid aortic valve, coarctation of the aorta), renal anomalies (e.g., horseshoe kidney), lymphedema in infancy, webbed neck, low posterior hairline, and characteristic neurocognitive profile (typically preserved verbal IQ with relative weaknesses in visuospatial processing and executive function). In reproductive medicine, Turner syndrome represents a major cause of hypergonadotropic hypogonadism and premature ovarian insufficiency. While spontaneous puberty occurs in ~20–30% of mosaic cases, most patients require exogenous estrogen replacement to induce secondary sexual characteristics and maintain bone health. Fertility remains extremely limited—spontaneous pregnancies are rare (<5%) and carry high obstetric risks; assisted reproductive technologies using donor oocytes are the primary fertility option, requiring careful preconception cardiovascular and endocrine evaluation. Quality of life is generally good with multidisciplinary care, yet challenges persist: lifelong hormone therapy adherence, psychosocial adjustment to infertility and physical differences, increased risk of autoimmune disorders (e.g., thyroiditis, celiac disease), hypertension, and osteoporosis. Early diagnosis—ideally in childhood or adolescence—enables timely growth hormone therapy, timely initiation of sex steroid replacement, cardiac surveillance, and psychosocial support, all of which significantly improve long-term outcomes, autonomy, and reproductive counseling access.

# 特纳综合征（Turner综合征）治疗方案与费用明细（生殖医学科）

一、非手术/保守/药物/理疗方案

• •生长激素治疗（GH）：适用于4岁至骨骺闭合前、身高落后≥−2.5 SDS者。含rhGH注射液（国产/进口）、骨龄监测、IGF-1动态检测。费用区间：3.8–8.2万元/年（含药费2.6–6.5万+检查费1.2–1.7万）。
• •雌激素替代治疗（EPT）：12–13岁起启动，分阶段（低剂量雌二醇贴片/口服+后期联合孕激素）。含性激素六项、盆腔超声、骨密度（DXA）年度评估。费用区间：0.3–0.9万元/年。
• •心理支持与生育力保存咨询：含遗传咨询、青春期发育评估、社会适应训练。费用：0.15–0.35万元/疗程（6–12次）。

二、手术/介入方案

• •辅助生殖技术（ART）：适用于卵巢功能早衰但仍有残存卵泡者，需行供卵IVF-ET。含促排卵监测、胚胎移植、黄体支持及多次周期尝试。全套费用：4.5–7.8万元/周期（含术前染色体核型+CNV-seq、AMH、窦卵泡计数等检查费0.4–0.6万元）。

三、特殊复杂方案

• •合并主动脉缩窄或严重心血管畸形者：需心内科协同评估后转心外科干预，生殖科主导生育力保存（如卵巢组织冻存），总费用12–25万元（含多学科会诊、冻存手术及长期随访）。

四、方案快速选择指南

• •儿童期（<10岁）：首选生长激素治疗（中档方案5.5万元/年）；
• •青春期启动期（12–15岁）：EPT+心理支持（预算0.5万元内优先）；
• •有生育需求成年女性：供卵IVF-ET（推荐三甲生殖中心，单周期预算≥5万元）；
• •合并严重器质病变者：启动MDT路径，预留15万元以上综合预算。